Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
1014.9000 8.80 (0.87%)
NSE Jun 09, 2025 15:31 PM
Volume: 212.3K
High volume today

logo
Alivus Life Sciences Ltd.
27 Jan 2023
1014.90
0.87%
buy
by BOB Capital Markets Ltd.
Target: 585
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
 
Number of FII/FPI investors increased from 92 to 105 in Mar 2025 qtr.
More from Alivus Life Sciences Ltd.
Recommended
IPOs This Week: Ganga Bath Fittings set to list; Oswal Pumps and Four New Issues
| 09 Jun 2025, 03:55PM
Market closes higher, Bank of Baroda cuts lending rate by 50 bps to 8.15%
Trendlyne Marketwatch | 09 Jun 2025, 03:54PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021